Abstract
Premenstrual syndrome (PMS) is a group of discomforting symptoms experienced by many women 7–10 days before menstruation. Typically, each woman has her own personal complex of symptoms and these occur cyclically, month after month. Common symptoms include tenderness and swelling of breasts, headaches, weight gain, abdominal cramps, bloating, thirst, nausea, specific food or alcohol cravings, joint pain, dizziness, acne, hyperalgesia, irritability, fatigue and lethargy, anxiety, depression, hostility and aggression. In most cases, symptoms cease completely within 24 h after the onset of menses.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Frank, R. T. (1931). The hormonal causes of premenstrual tension. Arch. Neurol. Psychiatr., 26, 1053.
Gray, L. A. (1941). Use of progesterone in nervous tension states. South. Med. J. 34, 1004.
Dalton, K. (1979). Once a Month. (Claremont, California: Hunter House).
Abraham, G.E. (1983). Nutritional factors in the etiology of the premenstrual tension syndromes. J. Reprod. Med., 28, 446.
Robinson, K., Humtington, R.M. and Wallace, M.G. (1977). Treatment of the premenstrual syndrome. Br. J. Obstet. Gynaecol., 87, 784.
Sutherland, H. and Stewart, I. (1965). A critical analysis of the premenstrual syndrome. Lancet, 1, 1180.
Budoff, P.W. (1980). No More Menstrual Cramps and Other Good News. (New York; G. P. Putnam’s Sons). Paperback Edition: (New York: Penguin Books) 1981.
Rosseinsky, D.R. and Hall, P. G. (1974). An evolutionary theory of premenstrual tension. Lancet, 2, 1024.
Hargrove, J. T. and Abraham, G.E. (1983). The ubiquitousness of premenstrual tension in gynecologic practice. J. Reprod. Med., 28, 435.
Reid, R.L. and Yen, S. S. C. (1981). Premenstrual syndrome. Am. J. Obstet. Gynecol., 139, 85.
Sharma, V. (1982). Premenstrual syndrome. Practitioner, 226, 1091.
Labrum, A. H. (1983). Hypothalamic, pineal and pituitary factors in the premenstrual syndrome. J. Reprod. Med., 28, 438.
Goldberg, V.J. and Ramwell, P. W. (1975). The role of prostaglandins in reproduction. Physiol. Rev., 55, 325.
Schwartz, A., Zor, U., Lindner, H.R. et al. (1974). Primary dysmenorrhea: allevation by an inhibitor of prostaglandin synthesis and action. Obstet. Gynecol., 44, 709.
Lindner, H. R., Zor, U., Kohen, F. et al. (1980). Significance of prostaglandins in the regulation of cyclic events in the ovary and uterus. In Samuelsson, B., Ramwell, P. W. and Paoletti, R. (eds.) Advances in Prostaglandin and Thromboxane Research. Vol. 8, pp. 1371–90. (New York: Raven Press).
Mitchell, M.D., Biddy, J. G., Hicks, B.R. et al. (1978). Possible role for prostacyclin in human parturition. Prostaglandins, 16, 931.
Chobsieng, P., Naor, Z., Koch Y. et al. (1975). Stimulatory effect of prostaglandin E2 on LH release in the rat: evidence for hypothalamic site of action. Neuroendocrinology, 17, 12.
Lindner, H.R., Tsafriri, A. and Lieberman, M.E. (1974). Gonadotropin action on cultured Graafian follicles: induction of maturation division of the mammalian oocyte and differentiation of the luteal cell. Recent Prog. Horm. Res., 30, 79.
Armstrong, D.T. and Grinwich, D.L. (1972). Blockade of spontaneous and LH-induced ovulation in rats by indomethacin, an inhibitor of prostaglandin biosynthesis. Prostaglandins, 1, 21.
Grinwich, D.L., Kennedy, T.G. and Armstrong, D.T. (1972). Dissociation of ovulatory and steroidogenic actions of luteinizing hormone in rabbits with indomethacin, an inhibitor of prostaglandin biosynthesis. Prostaglandins, 1, 89.
Caspo, A.I. (1980). A rationale for the treatment of dysmenorrhea. J. Reprod. Med. (Suppl.), 4, 213.
Ylikorkala, O. and Dawood, M.Y. (1978). New concepts in dysmenorrhea. Am. J. Obstet. Gynecol., 130, 833.
Budoff, P.W. (1981). Antiprostaglandins for primary dysmenorrhea. J. Am. Med. Assoc., 246, 2576.
Budoff, P.W. (1977). Treatment of dysmenorrhea. Am. J. Obstet. Gynecol., 129, 232.
Budoff, P.W. (1979). Use of mefenamic acid in the treatment of primary dysmenorrhea. J. Am. Med. Assoc., 241, 2713.
Henzl, M.R., Massey, S., Hanson, F.W. et al. (1980). Primary dysmenorrhea: the therapeutic challenge. J. Reprod. Med. (Suppl.), 25, 226.
Budoff, P.W. (1982). Zomepirac sodium in the treatment of primary dysmenorrhea syndrome. N. Engl. J. Med., 307, 714.
Buttram, V., Izu, A. and Henzl, M. R. (1978). Naproxen sodium in uterine pain following intrauterine contraceptive device insertion. Am. J. Obstet. Gynecol., 134, 575.
Davies, A.J., Anderson, A.B.M. and Turnbull, A.C. (1981). Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstet. Gynecol., 57,.
Jakubowicz, D. L. and Wood, C. (1978). The use of the prostaglandin synthetase inhibitor mefenamic acid in the treatment of menorrhagia. Aust. N. Z. J. Obstet. Gynaecol., 18, 135.
Massey, S.E., Varady, J. C. and Henzl, M.R. (1974). Pain relief with naproxen following insertion of an intrauterine device. J. Reprod. Med., 13, 226.
Wood, C, Larsen, L. and Williams, R. (1979). Menstrual characteristics of 2,343 women attending the Shepherd Foundation. Aust. N.Z. J. Obstet. Gynaecol, 19, 107.
Horrobin, D.F. (1979). Cellular basis of prolactin action: involvement of cyclic nucleotides, polyamines, prostaglandins, steroids, thyroid hormones, Na/K ATPases and calcium: relevance to breast cancer and the menstrual cycle. Med. Hypotheses, 5, 599.
Bennett, A., McDonald, A. M., Simpson, J. S. et al. (1975). Breast cancer, prostaglandins and bone metastases. Lancet, 1, 1218.
To, D., Smith, F. L. and Carpenter, M.P. (1980). Mammary gland prostaglandin synthesis: effect of dietary lipid and propyl gallate. In Samuelsson, B., Ramwell, P. W. and Paoletti, R. (eds.) Advances in Prostaglandin and Thromboxane Research. Vol. 1, pp. 1807–15. (New York: Raven Press).
Rolland, P.H., Martin, P.M., Rolland, A.M. et al. (1979). Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis. Obstet. Gynecol., 54, 715.
Ferreira, S. H. and Nakamura, M. (1980). Pathogenesis and phamacology of pain. In Weissmann, G., Paoletti, R. and Samuelsson, B. (eds.) Advances in Inflammation Research. Vol. 1, pp. 317–39. (New York: Raven Press).
Weissman, G., Smolen, J.E. and Korchak, H. (1970). Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells. In Samuelsson, B., Ramwell, P. W. and Paoletti, R. (eds.), Advances in Prostaglandin and Thromboxane Research. Vol. 8, pp. 1637–53. (New York: Raven Press).
Hamilton, T. and Rankin, M.E. (1975) Changes in volume of the breast during the menstrual cycle. Br. J. Surg. 62, 660.
Preece, P.E., Hughes, L.E., Baum, M. et al. (1977). Studies on breast pain. Br. J. Surg., 61, 322.
Preece, P.E., Hughes, L.E., Mansel, R.E. et al. (1976). Clinical syndromes of mastalgia. Lancet, 2, 670.
Wolfe, L. S. and Coceani, F. (1979). The role of prostaglandins in the central nervous system. Ann. Rev. Physiol., 41, 699.
Epstein, A. N. (1980). The neuroendocrinology of thirst and salt appetite. In Ganong W. F., and Martini, L. (eds.) Frontiers in Neuroendocrinology. Vol. 5, pp. 101–31. (New York: Raven Press).
Andersson, B. and Leksell, L. G. (1975). Effects on fluid balance of intraventricular infusions of prostaglandin E1. Acta Physiol. Scand., 93, 286.
Leksell, L. G. (1976). Influence of prostaglandin E1 on cerebral mechanisms involved in the control of fluid balance. Acta Physiol. Scand., 98, 85.
Scaramuzzi, O.E., Baile, C. A. and Mayer, J. (1971). Prostaglandins and food intake of rats. Experientia, 27, 256.
Baile, C.A., Simpson, C. W., Bean, S.M. et al. (1973). Prostaglandins and food intake of rats: A component of energy balance regulation? Physiol. Behav., 10, 1077.
Baile, C. A., Martin, F.H., Forbes, J. M. et al. (1974). Intrahypothalamic injections of prostaglandins and prostaglandin antagonists and feeding in sheep. J. Dairy Sci., 57, 81.
Horrobin, D.F. and Manku, M.S. (1980). Possible role of prostaglandin E1 in the affective disorders and in alcoholism. Br. Med. J., 280, 1363.
Horrobin, D.F. (1979). Schizophrenia: reconciliation of the dopamine, prostaglandin and opioid concepts and the role of the pineal. Lancet, 1, 529.
Horrobin, D.F. (1983). The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J. Reprod. Med., 28, 465.
Pickard, J.D., MacDonell, L.A., MacKenzie, E.T. et al. (1977). Prostaglandin-induced effects of the primate cerebral circulation. Eur. J. Pharmacol., 43, 343.
Wolfe, L. S. and Marner, O. A. (1975). Measurement of prostaglandin F2α levels in human cerebrospinal fluid in normal and pathological conditions. Prostaglandins, 9, 183.
Friesinger, G. C., Oelz, O., Sweetman, B. J. et al. (1978). Prostaglandin D2, another renal prostaglandin? Prostaglandins, 15, 969.
Grenier, F. C. and Smith, W. L. (1978). Formation of a 6-keto-prosta-glandin F1 by collecting duct cells isolated from rabbit renal papilla. Prostaglandins, 16, 759.
Lee, J.B., Covino, B. G., Takman, B.H. et al. (1965). Renal medullary vasodepressor substance, medullin: isolation, chemical characterization and physiological properties. Circ. Res., 17, 57.
Lee, J.B., Crowshaw, K., Takman, B.H. et al. (1967). The identification of prostaglandins E2, F2α and A2 from rabbit kidney medulla. Biochem. J., 105, 1251.
Hassid, A. and Dunn, M.J. (1980). Microsomal prostaglandin biosynthesis of human kidneys. J. Biol. Chem., 255, 2472.
Levenson, D.J., Simmons, C. E. and Brenner, B. M. (1982). Arachidonic acid metabolism, prostaglandins and the kidney. Am. J. Med., 72, 354.
Cadnapaphornchai, P. and Aisenbrey, G. (1978). Prostaglandin-mediated hyperemia and renin-mediated hypertension during acute ureteral obstruction. Prostaglandins, 16, 965.
Levy, J. V. (1977). Changes in systolic arterial blood pressure in normal. and spontaneously hypertensive rats produced by acute administration of inhibitors of prostaglandin biosynthesis. Prostaglandins, 13, 153.
Bowden, R.E., Gill, J.R., Radfar, N. et al. (1978). Prostaglandin synthetase inhibitors in Bartter’s syndrome. J. Am. Med. Assoc, 239, 117.
Linas, S. L. and Dickman, D. (1981). Mechanism of the decrease in renal blood flow in the potassium depleted conscious rat. Clin. Res., 29, 73.
Gerber, J. G. and Nies, A. S. (1979). The hemodynamic effects of prostaglandins in the rat: Evidence for important species variation in renovascular responses. Circ. Res., 44, 406.
Lee, J.B. (1980). Prostaglandins and the renin-angiotensin axis. Clin. Nephrol., 14, 159.
Zusman, R. M. (1981). Prostaglandins, vasopressin and renal water absorption. Med. Clin. N. Am., 65, 915.
Tannenbaum, J., Splawinski, J. A., Oates, J. A. et al. (1975). Enhanced renal prostaglandin production in the dog: I. Effects on renal function. Circ. Res., 36, 197.
Jamison, R. L. (1981). Urine concentrations and dilution: the role of antidiuretic hormone and urea. In Brenner, B. M. and Rector, F. C. (eds.) The Kidney. 2nd Edn., pp. 495–550. (Philadelphia: W. B. Saunders).
Moncada, S., Salmon, J. A., Vane, J. R. et al. (1978). Formation of prostacyclin and its product 6-oxo-PGF1α by the gastric mucosa of several species. J. Physiol., 275, 4.
Peskar, B.M., Seyberth, H.W. and Peskar, B.A. (1980). Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. In Samuelsson, B., Ramwell, P. W. and Paoletti, R. (eds.) Advances in Prostaglandin and Thromboxane Research. Vol. 8, pp. 1511–14. (New York: Raven Press).
Rask-Madsen, J. and Bukhave, K. (1980). Saturation kinetics applied to the inhibition by PGE2 of ion transport in the isolated human jejunum. In Samuelsson, B., Ramwell, P.W. and Paoletti, R. (eds.) Advances in Prostaglandin and Thromboxane Research. Vol. 8, pp. 1595–1601. (New York: Raven Press).
Whittle, B.J.R. (1981). Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 80, 94.
Robert, A., Nezamis, J. E., Lancaster, C. et al. (1979). Cytoprotection by prostaglandins in rats. Gastroenterology, 77, 433.
Main, I.H. M. and Whittle, B.J.R. (1975). Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br. J. Pharmacol., 53, 217.
Whittle, B.J.R. (1977). Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br. J. Pharmacol., 60, 455.
Allen, A. and Garner, A. (1980). Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut, 21, 249.
Lanza, F.L., Royer, G.L., Nelson, R.S. et al. (1979). The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers. Dig. Dis. Sci., 24, 823.
Pemberton, R.E. and Strand, L.J. (1979). A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents. Dig. Dis. Sci., 24, 53.
Rainsford, K.D., Peskar, B.M. and Brune, K. (1981). Relationship between inhibition of prostaglandin production and gastric mucosal damage induced by antiinflammatory drugs may depend on type of drugs and species. J. Pharm. Pharmacol., 33, 127.
Whittle, B.J.R., Higgs, G.A., Eakins, K.E. et al (1980). Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (London), 284, 271.
Northway, M. G., Bennett, A., Carroll, M. et al. (1980). Comparative effects of anti-inflammatory agents and radiotherapy on normal esophagus and tumors in animals. Gastroenterology, 78, 1229.
Borowska, A., Sierakowski, S., Mackowiak, J. et al. (1979). A prostaglandin-like activity in small intestine and postirradiation gastrointestinal syndrome. Experientia, 35, 1368.
Mennie, A.T., Dalley, V.M., Dineen, L. C. et al. (1975). Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet, 2, 942.
Buisseret, P. (1980). Drug treatment of allergic gastroenteritis. Am. J. Clin. Nutr., 33, 865.
Lieb, J. (1978). Prostaglandin-synthesis inhibitors in prophylaxis of food intolerance. Lancet, 2, 157.
Walker, S.L. (1973). Prostaglandins and the gastrointestinal tract. Gut, 14, 402.
Sharon, P., Ligumsky, M., Rachmilewitz, D. et al (1978). Role of prostaglandins in ulcerative colitis. Gastroenterology, 75, 638.
Goudl, S.R., Brash, A.R. and Conolly, M.E. (1977). Increased prostaglandin production in ulcerative colitis. Lancet, 2, 98.
Bennett, A. (1971). Cholera and prostaglandins. Nature (London), 231, 536.
Jacoby, H.I. and Marshall, C.H. (1972). Antagonism of cholera enterotoxin by anti-inflammatory agents in the rat. Nature (London), 235, 163.
Williams, E.D., Karim, S.M.M. and Sandler, M. (1968). Prostaglandin secretion by medullary carcinoma of the thyroid. Lancet, 1, 22.
Bennett, A. (1980). Prostaglandins as factors in diseases of the alimentary tract. In Samuelsson, B., Paoletti, R. and Ramwell, P. W. (eds.) Advances in Prostaglandin and Thromboxane Research. Vol. 2, pp. 547–55. (New York: Raven Press).
Steinhoff, M. C, Douglas, R.G., Greenberg, H.B. et al. (1980). Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology, 78, 1495.
Dalton, K. (1977). Premenstrual Syndrome and Progesterone Therapy. (New York: James H. Heinemann).
Jakubowicz, D. L. (1982). Personal communication.
Benedek-Jazmann, L. V. and Hearn-Sturtevant, M. D. (1976). Premenstrual tension and functional infertility: aetiology and treatment. Lancet, 1, 1095.
Ghose, K. and Coppen, A. (1977). Bromocriptine and premenstrual syndrome: controlled study. Br. Med. J., 1, 147.
O’Brien, P.M.S. (1982). The premenstrual syndrome: a review of the present status of therapy. Drugs, 24, 140.
Day, J. (1979). Danazol and the premenstrual syndrome. Postgrad. Med. J. (suppl.5), 55, 87.
London, R. S. et al. (1983). Effects of alpha tocopherol on premenstrual symptomatology: a double-blind study. J. Am. Col. Nutr., 2, 115.
Anderson, A.B.M., Haynes, P.J., Fraser, I. S. et al. (1978). Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. Lancet, 1, 345.
Wood, C. and Jakubowicz, D.L. (1980). The treatment of premenstrual symptoms with mefenamic acid. Br. J. Obstet. Gynaecol., 87, 627.
Jakubowicz, D.L., Godard, E. and Dewhurst, J. (1984). The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations. Br. J. Obstet. Gynaecol., 91, 78.
Budoff, P. W. (1985). Naproxen sodium vs. placebo in the treatment of premenstrual syndrome and fibrocystic breast disease. In Press.
Grizzle, J.E. (1965). The two-period change-over design and its use in clinical trials. Biometrics, 21, 467.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 MTP Press Limited
About this chapter
Cite this chapter
Budoff, P.W. (1986). Premenstrual syndrome. In: Bygdeman, M., Berger, G.S., Keith, L.G. (eds) Prostaglandins and their Inhibitors in Clinical Obstetrics and Gynaecology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6734-5_17
Download citation
DOI: https://doi.org/10.1007/978-94-011-6734-5_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6736-9
Online ISBN: 978-94-011-6734-5
eBook Packages: Springer Book Archive